Fundraising FoxContrafect
Yonkers, US · Delaware corporation
Find your way into Contrafect
Sign up to see every warm intro you have to Contrafect
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Contrafect team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JP
Julia P. GregoryExecutive
MM
Michael MessingerExecutive
MW
Michael Wittekind, Ph.D.Executive
NB
Natalie BogdanosExecutive
DH
David Huang, M.D., Ph.DExecutive
Board
LY
Lawrence Yuan Tian, Ph.D.Board director
DN
David N. Low, Jr.Board director
IB
Isaac BlechBoard director
RP
Roger Pomerantz, Ph.D.Board director
CS
Cary SucoffBoard director
MJ
Michael J. Otto, Ph.D.Board director
SB
Sol Barer, Ph.D.Board director
Reported raises · per SEC filings
Form D private placements$20M disclosed across 1 of 2 rounds · 2014–2015
▶$20MraisedJun 2015 · 9 investors · BiotechnologyRule 506(c)
▶$20MraisedJun 2015 · 9 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Roger Pomerantz, Ph.D.Director
- Cary SucoffDirector
- Julia P. GregoryExecutive Officer, Director
- Michael J. Otto, Ph.D.Director
- Michael MessingerExecutive Officer
- Lawrence Yuan Tian, Ph.D.Director
- Sol Barer, Ph.D.Director
- David N. Low, Jr.Director
- Michael Wittekind, Ph.D.Executive Officer
- Natalie BogdanosExecutive Officer
- David Scheinberg, M.D., Ph.D.Director
- Isaac BlechDirector
- Steven C. Gilman, Ph.D.Director
- Offering amount
- $20M
- Amount sold
- $20M
- Sales commissions
- $1.2M
- Placement agents
- Brookline Group, LLC, M.M. Dillon & Co. LLC
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶Undisclosed amountofferedMar 2014 · 1 investors · BiotechnologyRule 506(c)
▶Undisclosed amountofferedMar 2014 · 1 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Sir Richard Sykes, FRSDirector
- Julia P. GregoryExecutive Officer
- David Huang, M.D., Ph.DExecutive Officer
- Michael Wittekind, Ph.D.Executive Officer
- Cary SucoffDirector
- Shengda ZanDirector
- Isaac BlechDirector
- David Scheinberg, M.D., Ph.D.Director
- Sol Barer, Ph.D.Director
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Contrafect raised?
- Contrafect has disclosed $20M raised across 1 of its 2 known rounds.
- Where is Contrafect headquartered?
- Contrafect is headquartered in Yonkers, US.